Irinotecan trials for Metastatic Colorectal Cancer

All Irinotecan trials · All Metastatic Colorectal Cancer trials

Phase breakdown

Recruiting trials studying Irinotecan for Metastatic Colorectal Cancer

• 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
  NCT04689347 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
  NCT07543744 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 26 locations
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
  NCT04657068 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 164 locations
• MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
  NCT05462236 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials study Irinotecan for Metastatic Colorectal Cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.